Bionomics to Participate in William Blair's Biotech Focus Conference 2022

ADELAIDE, Australia, July 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (NASDAQ:BNOX , ASX: BNO)) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that Dr. Errol De Souza, Executive Chairman of Bionomics, will participate in a panel on "Unmet Needs and Novel Therapies in Neuropsychiatry" at the William Blair Biotech Focus Conference taking place virtually and in-person in New York on July 12-13, 2022. The "Unmet Needs and Novel Therapies in Neuropsychiatry" panel ... Full story available on Benzinga.com